MDAT
6,7-Methylenedioxy-2-aminotetralin
MDAT was developed in the 1990s by a team at Purdue University led by David E. Nichols.
MDAT appears to act as a serotonin releasing agent based on rodent drug discrimination assays comparing it to MDMA, in which it fully substitutes for, and additionally lacks any kind of serotonergic neurotoxicity.
MDAT is Not For Human Consumption.
MDAT was developed in the 1990s by a team at Purdue University led by David E. Nichols.
MDAT appears to act as a serotonin releasing agent based on rodent drug discrimination assays comparing it to MDMA, in which it fully substitutes for, and additionally lacks any kind of serotonergic neurotoxicity.
MDAT is Not For Human Consumption.
